JP2008519788A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519788A5
JP2008519788A5 JP2007540573A JP2007540573A JP2008519788A5 JP 2008519788 A5 JP2008519788 A5 JP 2008519788A5 JP 2007540573 A JP2007540573 A JP 2007540573A JP 2007540573 A JP2007540573 A JP 2007540573A JP 2008519788 A5 JP2008519788 A5 JP 2008519788A5
Authority
JP
Japan
Prior art keywords
dihydro
oxo
carboxy
dimethylamino
erythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007540573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519788A (ja
Filing date
Publication date
Priority claimed from GB0424959A external-priority patent/GB0424959D0/en
Application filed filed Critical
Publication of JP2008519788A publication Critical patent/JP2008519788A/ja
Publication of JP2008519788A5 publication Critical patent/JP2008519788A5/ja
Withdrawn legal-status Critical Current

Links

JP2007540573A 2004-11-11 2005-11-09 マクロロン−アミノ置換キノロン Withdrawn JP2008519788A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424959A GB0424959D0 (en) 2004-11-11 2004-11-11 Novel compounds
PCT/EP2005/012038 WO2006050942A1 (en) 2004-11-11 2005-11-09 Macrolones - amino substituted quinolones

Publications (2)

Publication Number Publication Date
JP2008519788A JP2008519788A (ja) 2008-06-12
JP2008519788A5 true JP2008519788A5 (https=) 2008-12-25

Family

ID=33523587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540573A Withdrawn JP2008519788A (ja) 2004-11-11 2005-11-09 マクロロン−アミノ置換キノロン

Country Status (19)

Country Link
US (2) US7718621B2 (https=)
EP (1) EP1824870A1 (https=)
JP (1) JP2008519788A (https=)
KR (1) KR20070085919A (https=)
CN (1) CN101098881A (https=)
AR (1) AR053311A1 (https=)
AU (1) AU2005303961A1 (https=)
BR (1) BRPI0517792A (https=)
CA (1) CA2587413A1 (https=)
GB (1) GB0424959D0 (https=)
IL (1) IL182978A0 (https=)
MA (1) MA29213B1 (https=)
MX (1) MX2007005776A (https=)
NO (1) NO20072939L (https=)
PE (1) PE20061137A1 (https=)
RU (1) RU2007121581A (https=)
TW (1) TW200630378A (https=)
WO (1) WO2006050942A1 (https=)
ZA (1) ZA200703603B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
JP2008540504A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用な4’’アミノ結合マクロライド
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
AU2008298545B2 (en) 2007-09-14 2013-12-12 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
CN106589023A (zh) * 2016-11-22 2017-04-26 宜昌东阳光药业股份有限公司 一种罗红霉素杂质及其合成方法
CN110475777B (zh) 2017-03-30 2022-04-15 豪夫迈·罗氏有限公司 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Similar Documents

Publication Publication Date Title
JP2008519788A5 (https=)
CA2548654C (en) Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
JP2025512474A5 (https=)
AU2011334602B2 (en) Compounds for treating respiratory syncytial virus infections
ES2732902T3 (es) Bencimidazol-2-aminas como inhibidores de MIDH1
JP2007516983A5 (https=)
CN103796654B (zh) 氘富集化4-羟基-5-甲氧基-n,1-二甲基-2-氧代-n-[(4-三氟-甲基)苯基]-1,2-二氢喹啉-3-甲酰胺
JP2016520618A5 (https=)
JP2007511613A5 (https=)
JP2020502049A5 (https=)
JP2009530424A5 (https=)
JP2010509375A5 (https=)
JP2005504055A5 (https=)
RU2007121581A (ru) Макролоны-аминозамещенные хинолоны
BRPI0714840A2 (pt) composto, processo para a preparaÇço e uso do mesmo, composiÇço farmacÊutica, processo para a preparaÇço da mesma, e, produto
JP2009519243A5 (https=)
ES2875737T3 (es) Derivados de 2-fenil-3H-imidazo[4,5-b]piridina útiles como inhibidores de la actividad tirosina quinasa de ROR1 de mamíferos
JP2008526999A5 (https=)
JP5925680B2 (ja) キナーゼインヒビター、そのプロドラッグ型および治療におけるそれらの使用
JP2010501478A5 (https=)
CN108025191A (zh) 治疗癌症的方法
JP2007516205A5 (https=)
JP2014511898A5 (https=)
JP2007501779A5 (https=)
ES2687826T3 (es) Arilhidrazidas que contienen una fracción de 2-piridona como agentes antibacterianos selectivos